Secreted Hsp90 is a novel regulator of the epithelial to mesenchymal transition (EMT) in prostate cancer

Journal of Biological Chemistry

Volumn 287, Issue 45, 2012, Pages 37732-37744

  Hance, Michael W ^a   Dole, Krystal ^a   Gopal, Udhayakumar ^a   Bohonowych, Jessica E ^a   Jezierska Drutel, Agnieszka ^a   Neumann, Carola A ^a   Liu, Haibo ^b   Garraway, Isla P ^b   Isaacs, Jennifer S ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL MOTILITY; EPITHELIAL TO MESENCHYMAL TRANSITIONS; MATRIX METALLOPROTEINASES; METASTATIC POTENTIAL; PROSTATE CANCERS;

DISEASES; ENZYME INHIBITION;

DIAGNOSIS;

GELATINASE A; GELATINASE B; HEAT SHOCK PROTEIN 90; MITOGEN ACTIVATED PROTEIN KINASE; UVOMORULIN;

ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; CANCER PROGNOSIS; CANCER SURVIVAL; CELL ACTIVATION; CELL ADHESION; CELL MOTILITY; CONTROLLED STUDY; DISEASE ASSOCIATION; EPITHELIAL MESENCHYMAL TRANSITION; GENE EXPRESSION REGULATION; HUMAN; HUMAN TISSUE; INTRACELLULAR SIGNALING; MALE; METASTASIS; MOLECULAR PATHOLOGY; PHENOTYPE; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; PROTEIN SECRETION; PROTEIN TARGETING; UPREGULATION;

ANTIBODIES, BLOCKING; BLOTTING, WESTERN; CELL LINE, TUMOR; CELL MOVEMENT; DIPEPTIDES; DISEASE PROGRESSION; EPITHELIAL-MESENCHYMAL TRANSITION; GENE EXPRESSION REGULATION, NEOPLASTIC; HEK293 CELLS; HSP90 HEAT-SHOCK PROTEINS; HUMANS; LOW DENSITY LIPOPROTEIN RECEPTOR-RELATED PROTEIN-1; MALE; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; PROSTATIC NEOPLASMS; PROTEASE INHIBITORS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA INTERFERENCE; SIGNAL TRANSDUCTION;

EID: 84868327473     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M112.389015     Document Type: Article

References (89)

1. Arya, M., Bott, S. R., Shergill, I. S., Ahmed, H. U., Williamson, M., and Patel, H. R. (2006) The metastatic cascade in prostate cancer. Surg. Oncol. 15, 117-1288
2. Crawford, E. D. (2009) Understanding the epidemiology, natural history, and key pathways involved in prostate cancer. Urology 73, S4-100
3. Jemal, A., Siegel, R., Ward, E., Hao, Y., Xu, J., and Thun, M. J. (2009) Cancer statistics, 2009. CA Cancer J. Clin. 59, 225-2499
4. Efstathiou, E., and Logothetis, C. J. (2010) A new therapy paradigm for prostate cancer founded on clinical observations. Clin. Cancer Res. 16, 1100-11077
5. Siegel, R., Naishadham, D., and Jemal, A. (2012) Cancer statistics, 2012. CA Cancer J. Clin. 62, 10-299
6. Culp, S., and Porter, M. (2009) The effect of obesity and lower serum prostate-specific antigen levels on prostate-cancer screening results in American men. BJU Int. 104, 1457-14611
7. Strope, S. A., and Andriole, G. L. (2010) Prostate cancer screening. Current status and future perspectives. Nat. Rev. Urol. 7, 487-4933
8. Andriole, G. L. (2009) Pathology. The lottery of conventional prostate biopsy. Nat. Rev. Urol. 6, 188-1899
9. Markert, E. K., Mizuno, H., Vazquez, A., and Levine, A. J. (2011) Molecular classification of prostate cancer using curated expression signatures. Proc. Natl. Acad. Sci. U.S.A. 108, 21276-212811
10. Polyak, K., and Weinberg, R. A. (2009) Transitions between epithelial and mesenchymal states. Acquisition of malignant and stem cell traits. Nat. Rev. Cancer 9, 265-2733
11. Thiery, J. P., Acloque, H., Huang, R. Y., and Nieto, M. A. (2009) Epithelialmesenchymal transitions in development and disease. Cell 139, 871-8900
12. Hanahan, D., and Weinberg, R. A. (2011) Hallmarks of cancer. The next generation. Cell 144, 646-6744
13. Onder, T. T., Gupta, P. B., Mani, S. A., Yang, J., Lander, E. S., and Weinberg, R. A. (2008) Loss of E-cadherin promotes metastasis via multiple downstream transcriptional pathways. Cancer Res. 68, 3645-36544
14. Zhau, H. E., Li, C. L., and Chung, L. W. (2000) Establishment of human prostate carcinoma skeletal metastasis models. Cancer 88, 2995-30011
15. Xu, J., Wang, R., Xie, Z. H., Odero-Marah, V., Pathak, S., Multani, A., Chung, L. W., and Zhau, H. E. (2006) Prostate cancer metastasis. Role of the host microenvironment in promoting epithelial to mesenchymal transition and increased bone and adrenal gland metastasis. Prostate 66, 1664-16733
16. Acevedo, V. D., Gangula, R. D., Freeman, K. W., Li, R., Zhang, Y., Wang, F., Ayala, G. E., Peterson, L. E., Ittmann, M., and Spencer, D. M. (2007) Inducible FGFR-1 activation leads to irreversible prostate adenocarcinoma and an epithelial-to-mesenchymal transition. Cancer Cell 12, 559-5711
17. Zhang, X., Fournier, M. V., Ware, J. L., Bissell, M. J., Yacoub, A., and Zehner, Z. E. (2009) Inhibition of vimentin or β1-integrin reverts morphology of prostate tumor cells grown in laminin-rich extracellular matrix gels and reduces tumor growth in vivo. Mol. Cancer Ther. 8, 499-5088
18. Mak, P., Leav, I., Pursell, B., Bae, D., Yang, X., Taglienti, C. A., Gouvin, L. M., Sharma, V. M., and Mercurio, A. M. (2010) ERβ impedes prostate cancer EMT by destabilizing HIF-1α and inhibiting VEGF-mediated snail nuclear localization. Implications for Gleason grading. Cancer Cell 17, 319-3322
19. Lue, H. W., Yang, X., Wang, R., Qian, W., Xu, R. Z., Lyles, R., Osunkoya, A. O., Zhou, B. P., Vessella, R. L., Zayzafoon, M., Liu, Z. R., Zhau, H. E., and Chung, L. W. (2011) LIV-1 promotes prostate cancer epithelial-to-mesenchymal transition and metastasis through HB-EGF shedding and EGFR-mediated ERK signaling. PLoS One 6, e277200
20. Xie, D., Gore, C., Liu, J., Pong, R. C., Mason, R., Hao, G., Long, M., Kabbani, W., Yu, L., Zhang, H., Chen, H., Sun, X., Boothman, D. A., Min, W., and Hsieh, J. T. (2010) Role of DAB2IP in modulating epithelial-to-mesenchymal transition and prostate cancer metastasis. Proc. Natl. Acad. Sci. U.S.A. 107, 2485-24900
21. Kwok, W. K., Ling, M. T., Lee, T. W., Lau, T. C., Zhou, C., Zhang, X., Chua, C. W., Chan, K. W., Chan, F. L., Glackin, C., Wong, Y. C., and Wang, X. (2005) Up-regulation of TWIST in prostate cancer and its implication as a therapeutic target. Cancer Res. 65, 5153-51622
22. Graham, T. R., Zhau, H. E., Odero-Marah, V. A., Osunkoya, A. O., Kimbro, K. S., Tighiouart, M., Liu, T., Simons, J. W., and O'Regan, R. M. (2008) Insulin-like growth factor I-dependent up-regulation of ZEB1 drives epithelial-to-mesenchymal transition in human prostate cancer cells. Cancer Res. 68, 2479-24888
23. Contreras, H. R., Ledezma, R. A., Vergara, J., Cifuentes, F., Barra, C., Cabello, P., Gallegos, I., Morales, B., Huidobro, C., and Castellón, E. A. (2010) The expression of syndecan-1 and -2 is associated with Gleason score and epithelial-mesenchymal transition markers, E-cadherin and β-catenin, in prostate cancer. Urol. Oncol. 28, 534-5400
24. Zhang, Q., Helfand, B. T., Jang, T. L., Zhu, L. J., Chen, L., Yang, X. J., Kozlowski, J., Smith, N., Kundu, S. D., Yang, G., Raji, A. A., Javonovic, B., Pins, M., Lindholm, P., Guo, Y., Catalona, W. J., and Lee, C. (2009) Nuclear factor-βB-mediated transforming growth factor-β-induced expression of vimentin is an independent predictor of biochemical recurrence after radical prostatectomy. Clin. Cancer Res. 15, 3557-35677
25. Sun, Y., Wang, B. E., Leong, K. G., Yue, P., Li, L., Jhunjhunwala, S., Chen, D., Seo, K., Modrusan, Z., Gao, W. Q., Settleman, J., and Johnson, L. (2012) Androgen deprivation causes epithelial-mesenchymal transition in the prostate. Implications for androgen-deprivation therapy. Cancer Res. 72, 527-5366
26. Isaacs, J. S., Xu, W., and Neckers, L. (2003) Heat shock protein 90 as a molecular target for cancer therapeutics. Cancer Cell 3, 213-2177
27. Whitesell, L., and Lindquist, S. L. (2005) HSP90 and the chaperoning of cancer. Nat. Rev. Cancer 5, 761-7722
28. Bohonowych, J. E., Gopal, U., and Isaacs, J. S. (2010) Hsp90 as a gatekeeper of tumor angiogenesis. Clinical promise and potential pitfalls. J. Oncol. 2010, 4129855
29. Cheng, C. F., Fan, J., Fedesco, M., Guan, S., Li, Y., Bandyopadhyay, B., Bright, A. M., Yerushalmi, D., Liang, M., Chen, M., Han, Y. P., Woodley, D. T., and Li, W. (2008) Transforming growth factorα (TGFα)-stimulated secretion of HSP90α. Using the receptor LRP-1/CD91 to promote human skin cell migration against a TGFα-rich environment during wound healing. Mol. Cell. Biol. 28, 3344-33588
30. Gopal, U., Bohonowych, J. E., Lema-Tome, C., Liu, A., Garrett-Mayer, E., Wang, B., and Isaacs, J. S. (2011) A novel extracellular Hsp90 mediated co-receptor function for LRP1 regulates EphA2-dependent glioblastoma cell invasion. PLoS One 6, e176499
31. Becker, B., Multhoff, G., Farkas, B., Wild, P. J., Landthaler, M., Stolz, W., and Vogt, T. (2004) Induction of Hsp90 protein expression in malignant melanomas and metastases. Exp. Dermatol. 13, 27-322
32. Eustace, B. K., Sakurai, T., Stewart, J. K., Yimlamai, D., Unger, C., Zehetmeier, C., Lain, B., Torella, C., Henning, S. W., Beste, G., Scroggins, B. T., Neckers, L., Ilag, L. L., and Jay, D. G. (2004) Functional proteomic screens reveal an essential extracellular role for hsp90α in cancer cell invasiveness. Nat. Cell Biol. 6, 507-5144
33. Sidera, K., Gaitanou, M., Stellas, D., Matsas, R., and Patsavoudi, E. (2008)A critical role for HSP90 in cancer cell invasion involves interaction with the extracellular domain of HER-2. J. Biol. Chem. 283, 2031-20411
34. Yang, Y., Rao, R., Shen, J., Tang, Y., Fiskus, W., Nechtman, J., Atadja, P., and Bhalla, K. (2008) Role of acetylation and extracellular location of heat shock protein 90α in tumor cell invasion. Cancer Res. 68, 4833-48422
35. Stellas, D., El Hamidieh, A., and Patsavoudi, E. (2010) Monoclonal antibody 4C5 prevents activation of MMP2 and MMP9 by disrupting their interaction with extracellular HSP90 and inhibits formation of metastatic breast cancer cell deposits. BMC Cell Biol. 11, 511
36. Tsutsumi, S., Scroggins, B., Koga, F., Lee, M. J., Trepel, J., Felts, S., Carreras, C., and Neckers, L. (2008) A small molecule cell-impermeant Hsp90 antagonist inhibits tumor cell motility and invasion. Oncogene 27, 2478-24877
37. Wang, X., Song, X., Zhuo, W., Fu, Y., Shi, H., Liang, Y., Tong, M., Chang, G., and Luo, Y. (2009) The regulatory mechanism of Hsp90α secretion and its function in tumor malignancy. Proc. Natl. Acad. Sci. U.S.A. 106, 21288-212933
38. Sahu, D., Zhao, Z., Tsen, F., Cheng, C. F., Park, R., Situ, A. J., Dai, J., Eginli, A., Shams, S., Chen, M., Ulmer, T. S., Conti, P., Woodley, D. T., and Li, W. (2012) A potentially common peptide target in secreted heat shock protein-90α for hypoxia-inducible factor-1α-positive tumors. Mol. Biol. Cell 23, 602-6133
39. Ullrich, S. J., Robinson, E. A., Law, L. W., Willingham, M., and Appella, E. (1986) A mouse tumor-specific transplantation antigen is a heat shockrelated protein. Proc. Natl. Acad. Sci. U.S.A. 83, 3121-31255
40. Luo, L. Y., Herrera, I., Soosaipillai, A., and Diamandis, E. P. (2002) Identification of heat shock protein 90 and other proteins as tumor antigens by serological screening of an ovarian carcinoma expression library. Br. J. Cancer 87, 339-3433
41. Burgess, E. F., Ham, A. J., Tabb, D. L., Billheimer, D., Roth, B. J., Chang, S. S., Cookson, M. S., Hinton, T. J., Cheek, K. L., Hill, S., and Pietenpol, J. A. (2008) Prostate cancer serum biomarker discovery through proteomic analysis ofα2-macroglobulin protein complexes. Proteomics Clin. Appl. 2, 1223-12333
42. Garraway, I. P., Sun, W., Tran, C. P., Perner, S., Zhang, B., Goldstein, A. S., Hahm, S. A., Haider, M., Head, C. S., Reiter, R. E., Rubin, M. A., and Witte, O. N. (2010) Human prostate sphere-forming cells represent a subset of basal epithelial cells capable of glandular regeneration in vivo. Prostate 70, 491-5011
43. Stellas, D., El Hamidieh, A., and Patsavoudi, E. (2010) Monoclonal antibody 4C5 prevents activation of MMP2 and MMP9 by disrupting their interaction with extracellular HSP90 and inhibits formation of metastatic breast cancer cell deposits. BMC Cell Biol. 11, 511
44. Qin, Z., DeFee, M., Isaacs, J. S., and Parsons, C. (2010) Extracellular Hsp90 serves as a co-factor for MAPK activation and latent viral gene expression during de novo infection by KSHV. Virology 403, 92-1022
45. Orr, A. W., Pedraza, C. E., Pallero, M. A., Elzie, C. A., Goicoechea, S., Strickland, D. K., and Murphy-Ullrich, J. E. (2003) Low density lipoprotein receptor-related protein is a calreticulin coreceptor that signals focal adhesion disassembly. J. Cell Biol. 161, 1179-11899
46. Shi, Y., Mantuano, E., Inoue, G., Campana, W. M., and Gonias, S. L. (2009) Ligand binding to LRP1 transactivates Trk receptors by a Src family kinase-dependent pathway. Sci. Signal 2, ra188
47. Langlois, B., Perrot, G., Schneider, C., Henriet, P., Emonard, H., Martiny, L., and Dedieu, S. (2010) LRP-1 promotes cancer cell invasion by supporting ERK and inhibiting JNK signaling pathways. PLoS One 5, e115844
48. Zhau, H. Y., Chang, S. M., Chen, B. Q., Wang, Y., Zhang, H., Kao, C., Sang, Q. A., Pathak, S. J., and Chung, L. W. (1996) Androgen-repressed phenotype in human prostate cancer. Proc. Natl. Acad. Sci. U.S.A. 93, 15152-151577
49. He, H., Yang, X., Davidson, A. J., Wu, D., Marshall, F. F., Chung, L. W., Zhau, H. E., and Wang, R. (2010) Progressive epithelial to mesenchymal transitions in ARCaP E prostate cancer cells during xenograft tumor formation and metastasis. Prostate 70, 518-5288
50. Zhau, H. E., Odero-Marah, V., Lue, H. W., Nomura, T., Wang, R., Chu, G., Liu, Z. R., Zhou, B. P., Huang, W. C., and Chung, L. W. (2008) Epithelial to mesenchymal transition (EMT) in human prostate cancer. Lessons learned from ARCaP model. Clin. Exp. Metastasis 25, 601-6100
51. 2-Microglobulin induces epithelial to mesenchymal transition and confers cancer lethality and bone metastasis in human cancer cells. Cancer Res. 71, 2600-26100
52. Bae, V. L., Jackson-Cook, C. K., Maygarden, S. J., Plymate, S. R., Chen, J., and Ware, J. L. (1998) Metastatic sublines of an SV40 large T antigen immortalized human prostate epithelial cell line. Prostate 34, 275-2822
53. Rojas, A., Liu, G., Coleman, I., Nelson, P. S., Zhang, M., Dash, R., Fisher, P. B., Plymate, S. R., and Wu, J. D. (2011) IL-6 promotes prostate tumorigenesis and progression through autocrine cross-activation of IGF-IR. Oncogene 30, 2345-23555
54. Fu, X., Herrera, H., and Hoffman, R. M. (1992) Orthotopic growth and metastasis of human prostate carcinoma in nude mice after transplantation of histologically intact tissue. Int. J. Cancer 52, 987-9900
55. Stephenson, R. A., Dinney, C. P., Gohji, K., Ordóñez, N. G., Killion, J. J., and Fidler, I. J. (1992) Metastatic model for human prostate cancer using orthotopic implantation in nude mice. J. Natl. Cancer Inst. 84, 951-9577
56. Thalmann, G. N., Anezinis, P. E., Chang, S. M., Zhau, H. E., Kim, E. E., Hopwood, V. L., Pathak, S., von Eschenbach, A. C., and Chung, L. W. (1994) Androgen-independent cancer progression and bone metastasis in the LNCaP model of human prostate cancer. Cancer Res. 54, 2577-25811
57. Smolen, G. A., Zhang, J., Zubrowski, M. J., Edelman, E. J., Luo, B., Yu, M., Ng, L. W., Scherber, C. M., Schott, B. J., Ramaswamy, S., Irimia, D., Root, D. E., and Haber, D. A. (2010) A genome-wide RNAi screen identifies multiple RSK-dependent regulators of cell migration. Genes Dev. 24, 2654-26655
58. Janda, C. Y., Li, J., Oubridge, C., Hernández, H., Robinson, C. V., and Nagai, K. (2010) Recognition of a signal peptide by the signal recognition particle. Nature 465, 507-5100
59. Figueiredo, C., Wittmann, M., Wang, D., Dressel, R., Seltsam, A., Blasczyk, R., and Eiz-Vesper, B. (2009) Heat shock protein 70 (HSP70) induces cytotoxicity of T-helper cells. Blood 113, 3008-30166
60. Thiery, J. P. (2003) Epithelial-mesenchymal transitions in development and pathologies. Curr. Opin. Cell Biol. 15, 740-7466
61. Polette, M., Gilles, C., Nawrocki-Raby, B., Lohi, J., Hunziker, W., Foidart, J. M., and Birembaut, P. (2005) Membrane-type 1 matrix metalloproteinase expression is regulated by zonula occludens-1 in human breast cancer cells. Cancer Res. 65, 7691-76988
62. Chambers, A. F., and Matrisian, L. M. (1997) Changing views of the role of matrix metalloproteinases in metastasis. J. Natl. Cancer Inst. 89, 1260-12700
63. Nistico, P., Bissell, M. J., and Radisky, D. C. (2012) Cold Spring Harbor Perspect. Biol. 44
64. Radisky, D. C., Levy, D. D., Littlepage, L. E., Liu, H., Nelson, C. M., Fata, J. E., Leake, D., Godden, E. L., Albertson, D. G., Nieto, M. A., Werb, Z., and Bissell, M. J. (2005) Rac1b and reactive oxygen species mediate MMP-3-induced EMT and genomic instability. Nature 436, 123-1277
65. Lagarrigue, F., Dupuis-Coronas, S., Ramel, D., Delsol, G., Tronchère, H., Payrastre, B., and Gaits-Iacovoni, F. (2010) Matrix metalloproteinase-9 is up-regulated in nucleophosmin-anaplastic lymphoma kinase-positive anaplastic lymphomas and activated at the cell surface by the chaperone heat shock protein 90 to promote cell invasion. Cancer Res. 70, 6978-69877
66. Song, X., Wang, X., Zhuo, W., Shi, H., Feng, D., Sun, Y., Liang, Y., Fu, Y., Zhou, D., and Luo, Y. (2010) The regulatory mechanism of extracellular Hsp90α on matrix metalloproteinase-2 processing and tumor angiogenesis. J. Biol. Chem. 285, 40039-400499
67. Ito, H., Duxbury, M., Benoit, E., Clancy, T. E., Zinner, M. J., Ashley, S. W., and Whang, E. E. (2004) Prostaglandin E2 enhances pancreatic cancer invasiveness through an Ets-1-dependent induction of matrix metalloproteinase-2. Cancer Res. 64, 7439-74466
68. Yoshida, T., Hisamoto, T., Akiba, J., Koga, H., Nakamura, K., Tokunaga, Y., Hanada, S., Kumemura, H., Maeyama, M., Harada, M., Ogata, H., Yano, H., Kojiro, M., Ueno, T., Yoshimura, A., and Sata, M. (2006) Spreds, inhibitors of the Ras/ERK signal transduction, are dysregulated in human hepatocellular carcinoma and linked to the malignant phenotype of tumors. Oncogene 25, 6056-60666
69. Hinck, L., Näthke, I. S., Papkoff, J., and Nelson, W. J. (1994) Dynamics of cadherin/catenin complex formation. Novel protein interactions and pathways of complex assembly. J. Cell Biol. 125, 1327-13400
70. Liwosz, A., Lei, T., and Kukuruzinska, M. A. (2006) N-Glycosylation affects the molecular organization and stability of E-cadherin junctions. J. Biol. Chem. 281, 23138-231499
71. Batlle, E., Sancho, E., Francí, C., Domínguez, D., Monfar, M., Baulida, J., and García De Herreros, A. (2000) The transcription factor snail is a repressor of E-cadherin gene expression in epithelial tumor cells. Nat. Cell Biol. 2, 84-899
72. Cano, A., Pérez-Moreno, M. A., Rodrigo, I., Locascio, A., Blanco, M. J., del Barrio, M. G., Portillo, F., and Nieto, M. A. (2000) The transcription factor snail controls epithelial-mesenchymal transitions by repressing E-cadherin expression. Nat. Cell Biol. 2, 76-833
73. Grooteclaes, M. L., and Frisch, S. M. (2000) Evidence for a function of CtBP in epithelial gene regulation and anoikis. Oncogene 19, 3823-38288
74. Yang, J., Mani, S. A., Donaher, J. L., Ramaswamy, S., Itzykson, R. A., Come, C., Savagner, P., Gitelman, I., Richardson, A., and Weinberg, R. A. (2004) Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis. Cell 117, 927-9399
75. Johnson, T. R., Koul, S., Kumar, B., Khandrika, L., Venezia, S., Maroni, P. D., Meacham, R. B., and Koul, H. K. (2010) Loss of PDEF, a prostatederived Ets factor is associated with aggressive phenotype of prostate cancer. Regulation of MMP-9 by PDEF. Mol. Cancer 9, 1488
76. Jordà, M., Olmeda, D., Vinyals, A., Valero, E., Cubillo, E., Llorens, A., Cano, A., and Fabra, A. (2005) Up-regulation of MMP-9 in MDCK epithelial cell line in response to expression of the Snail transcription factor. J. Cell Sci. 118, 3371-33855
77. Sun, L., Diamond, M. E., Ottaviano, A. J., Joseph, M. J., Ananthanarayan, V., and Munshi, H. G. (2008) Transforming growth factor-β1 promotes matrix metalloproteinase-9-mediated oral cancer invasion through snail expression. Mol. Cancer Res. 6, 10-200
78. Zhao, X. L., Sun, T., Che, N., Sun, D., Zhao, N., Dong, X. Y., Gu, Q., Yao, Z., and Sun, B. C. (2011) Promotion of hepatocellular carcinoma metastasis through matrix metalloproteinase activation by epithelial-mesenchymal transition regulator Twist1. J. Cell Mol. Med. 15, 691-7000
79. Sims, J. D., McCready, J., and Jay, D. G. (2011) Extracellular heat shock protein (Hsp)70 and Hsp90α assist in matrix metalloproteinase-2 activation and breast cancer cell migration and invasion. PLoS One 6, e188488
80. Ellenrieder, V., Hendler, S. F., Boeck, W., Seufferlein, T., Menke, A., Ruhland, C., Adler, G., and Gress, T. M. (2001) Transforming growth factor-β1 treatment leads to an epithelial-mesenchymal transdifferentiation of pancreatic cancer cells requiring extracellular signal-regulated kinase 2 activation. Cancer Res. 61, 4222-42288
81. Vial, E., Sahai, E., and Marshall, C. J. (2003) ERK-MAPK signaling coordinately regulates activity of Rac1 and RhoA for tumor cell motility. Cancer Cell 4, 67-799
82. Doehn, U., Hauge, C., Frank, S. R., Jensen, C. J., Duda, K., Nielsen, J. V., Cohen, M. S., Johansen, J. V., Winther, B. R., Lund, L. R., Winther, O., Taunton, J., Hansen, S. H., and Frödin, M. (2009) RSK is a principal effector of the RAS-ERK pathway for eliciting a coordinate promotile/invasive gene program and phenotype in epithelial cells. Mol. Cell 35, 511-5222
83. Shin, S., Dimitri, C. A., Yoon, S. O., Dowdle, W., and Blenis, J. (2010) ERK2 but not ERK1 induces epithelial-to-mesenchymal transformation via DEF motif-dependent signaling events. Mol. Cell 38, 114-1277
84. Johnson, J. L., Dwivedi, A., Somerville, M., George, S. J., and Newby, A. C. (2011) Matrix metalloproteinase (MMP)-3 activates MMP-9 mediated vascular smooth muscle cell migration and neointima formation in mice. Arterioscler. Thromb. Vasc. Biol. 31, e35-444
85. David, J. M., and Rajasekaran, A. K. (2012) Dishonorable discharge. The oncogenic roles of cleaved E-cadherin fragments. Cancer Res. 72, 2917-29233
86. Hahn-Dantona, E., Ruiz, J. F., Bornstein, P., and Strickland, D. K. (2001) The low density lipoprotein receptor-related protein modulates levels of matrix metalloproteinase 9 (MMP-9) by mediating its cellular catabolism. J. Biol. Chem. 276, 15498-155033
87. Mantuano, E., Inoue, G., Li, X., Takahashi, K., Gaultier, A., Gonias, S. L., and Campana, W. M. (2008) The hemopexin domain of matrix metalloproteinase-9 activates cell signaling and promotes migration of Schwann cells by binding to low-density lipoprotein receptor-related protein. J. Neurosci. 28, 11571-115822
88. Vidal, C. I., Mintz, P. J., Lu, K., Ellis, L. M., Manenti, L., Giavazzi, R., Gershenson, D. M., Broaddus, R., Liu, J., Arap, W., and Pasqualini, R. (2004) An HSP90-mimic peptide revealed by fingerprinting the pool of antibodies from ovarian cancer patients. Oncogene 23, 8859-88677
89. Tanaka, H., Kono, E., Tran, C. P., Miyazaki, H., Yamashiro, J., Shimomura, T., Fazli, L., Wada, R., Huang, J., Vessella, R. L., An, J., Horvath, S., Gleave, M., Rettig, M. B., Wainberg, Z. A., and Reiter, R. E. (2010) Monoclonal antibody targeting of N-cadherin inhibits prostate cancer growth, metastasis and castration resistance. Nat. Med. 16, 1414-14200